Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPB2 | Q96IY4 | 13/20 | 0.47 |
| ▸ | CPB1 | P15086 | 5/20 | 0.47 |
| ▸ | CPA1 | P15085 | 1/20 | 0.43 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20520508 | 0.75 | CPB2 (0.47) | CPB2CPB1CPA1HRH4HRH3 | |
| SCHEMBL5912570 | 0.72 | CPB2 (0.54) | CPB2CPB1CPA1HRH4HRH3 | |
| SCHEMBL5692253 | 0.71 | CPB2 (0.50) | CPB2CPB1CPA1HRH4HRH3 | |
| SCHEMBL27304198 | 0.70 | CPB2 (0.46) | CPB2CPB1CPA1CYP3A4SLC7A5 | |
| SCHEMBL21686619 | 0.69 | CPA1 (0.51) | CPB2CPB1CPA1HRH4HRH3 | |
| SCHEMBL18769064 | 0.68 | CPB2 (0.62) | CPB2CPB1CPA1 | |
| SCHEMBL17662386 | 0.68 | CPB2 (0.46) | CPB2CPB1CPA1HRH4HRH3 | |
| SCHEMBL14948139 | 0.68 | CPB2 (0.49) | CPB2CPB1CPA1HRH4HRH3 | |
| SCHEMBL18912207 | 0.68 | ACR (0.48) | CPB2CPB1HRH4HRH3 | |
| SCHEMBL6647445 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016096590-A1 | SYNTHETIC ENZYME MIMIC BASED ON A HISTIDINE SCAFFOLD | UNILEVER PLC (GB) | 2016-06-23 | — | — | WO | disclosed |
| WO-2016096589-A1 | SYNTHETIC ENZYME MIMIC BASED ON A HISTIDINE SCAFFOLD | UNILEVER PLC (GB) | 2016-06-23 | — | — | WO | disclosed |